Through a unique cancer treatment approach, Cyteir Therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. Currently in development, is the answer to the oncology triumvirate: reducing side effects, reducing therapy resistance, inducing diseased cell self destruction.

Research

Cyteir Therapeutics

Cyteir Therapeutics' headquarters in Lexington, MA, United States

Teresa Newman

Krisztina Nemenyi

John Thero

Joseph S. Zakrzewski

Jean George

This department provides strategic direction and governance for the organization.

Executive Leadership

The Clinical and Regulatory Operations team at Cyteir Therapeutics oversees the design, implementation, and management of clinical trials, ensures compliance with regulatory standards, and maintains quality assurance throughout the drug development process. They collaborate to advance the company's innovative oncology treatments from preclinical stages through clinical trials, aiming to reduce side effects, therapy resistance, and induce diseased cell self-destruction.

Clinical and Regulatory Operations

The Leadership Team at Cyteir Therapeutics is responsible for guiding the company's strategic vision and operational execution in the development of innovative cancer therapies. Composed of key executives, including the President & CEO and senior vice presidents in clinical operations and pharmacology, this team collaborates to advance research initiatives, streamline clinical trials, and ensure the alignment of therapeutic goals with patient needs, ultimately driving the company's mission to revolutionize cancer treatment.

Cyteir Therapeutics

Org chart

Board & advisors

Teams

Executive Leadership

Clinical and Regulatory Operations

Leadership Team

Offices

Cyteir Therapeutics

Org chart

Board & advisors

Teams

Executive Leadership

Clinical and Regulatory Operations

Leadership Team

Offices

Related companies